VivoSim Expands NAMKind Toxicology Platform to Asia‑Pacific, Boosting Investor Interest
VivoSim Labs expands its NAMKind toxicology platform into Asia‑Pacific via JCBio and Tekon Biotech, delivering 30‑day human‑based liver & GI safety insights for faster drug development.
3 minutes to read